PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 2, 2026Nucleus0 citationsOpen Access

Passive nuclear transport deviates from Fickian behavior in prostate and breast cell types

View Full Paper
NSNicholas R. ScottALAlexander J LinBBBrian Belardi

Key Points

  • This research aims to understand how passive nuclear transport varies among different cell types and phenotypes.
  • Investigated passive nuclear transport of fluorescent molecules across various cell lines.
  • Assessed transport behavior in relation to molecular weight ranging from 500-20,000 Da.
  • Applied TGF-Beta treatment to convert healthy cells into an invasive-like phenotype.
  • Identified cell-line-specific nuclear restrictions affecting passive nuclear uptake.
  • Found non-monotonic molecular weight dependence for passive nuclear transport.
  • Noted that the invasive-like phenotype showed nuclear transport characteristics similar to invasive breast cancer cells.

Abstract

Nuclear trafficking is essential for cellular function and biomedical applications such as nucleus-targeted drug delivery; however, how passive nuclear transport varies across cell types and phenotypic states remains poorly understood. Here, we investigate passive nuclear transport of fluorescent molecular cargoes spanning 500-20,000 Da across multiple cell lines. We observe cell-line-specific nuclear restrictions and find that passive nuclear uptake does not exhibit a monotonic dependence on molecular weight, suggesting non-Fickian transport behavior. Furthermore, transforming a healthy breast cell model into an invasive-like phenotype via TGF-Beta treatment significantly altered passive nuclear transport characteristics, closely resembling those of a well-established invasive breast cancer cell line. These phenotype-dependent changes in nuclear permeability provide new insight into fundamental biophysical alterations associated with cancerous cellular transformation.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Scott et al. (2026) studied this question.

synapsesocial.com/papers/6980ff37c1c9540dea811fbbhttps://doi.org/10.1080/19491034.2026.2620223
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localization2000 · 98 citations
  2. 2Domain antibodies: proteins for therapy2003 · 345 citations
  3. 3Dynamic control of TGF‐β signaling and its links to the cytoskeleton2008 · 124 citations
  4. 4p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a2007 · 271 citations
  5. 5Expression and Functional Characterization of Tumor-Targeted Fusion Protein Composed of NGR Peptide and 15-kDa Actin Fragment2010 · 12 citations